Class II
Ongoing
Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300,…
Why: CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
- Company
- Cipla USA, Inc.
Warren, NJ, United States - Reported
- Apr 22, 2026
- Recall started
- Mar 16, 2026
- Where sold
- Nationwide in the USA
- Amount
- 113,336 bottles
- Full product description
- Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-410-02
- Lots / codes affected
- Lot, expiry: Lot 4PB0526, 4PB0527, 4PB0528, exp September-2026; Lot 5PB0173, exp January-2027
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.